Voloridge Investment Management
VIVO

Voloridge Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History

Voloridge Investment Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-134,419
Closed -$4.46M – 1693
2022
Q4 		$4.46M Buy
134,419
+10,635
+9% +$343K 0.02% 680
2022
Q3 		$3.9M Buy
123,784
+76,773
+163% +$2.49M 0.02% 738
2022
Q2 		$1.43M Buy
+47,011
New +$1.27M 0.01% 1103
2020
Q4 		– Sell
-193,880
Closed -$3.29M – 1647
2020
Q3 		$3.29M Buy
193,880
+99,109
+105% +$1.93M 0.03% 564
2020
Q2 		$2.21M Buy
+94,771
New +$1.37M 0.03% 589

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Voloridge Investment Management's VIVO Position: Q1 2023 in Review

Voloridge Investment Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 134,419 shares — an estimated $4.46M sold.

Voloridge Investment Management first reported a position in VIVO in Q2 2020 and held it in 5 quarters. The position peaked at $4.46M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Voloridge Investment Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 134,419 Meridian Bioscience Inc shares in Q1 2023, an estimated $4.46M.
  • Voloridge Investment Management first reported a position in Meridian Bioscience Inc in Q2 2020 and held it in 5 quarters.
  • Voloridge Investment Management's Meridian Bioscience Inc position peaked at $4.46M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Voloridge Investment Management's 13F filing for Q1 2023, filed 15 May 2023.